Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 
The feature you requested does not exist. However, we suggest the following feature:

Levi & Korsinsky, LLP Notifies Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 - LBIO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/25/2017 | 10:23pm CEST

NEW YORK, NY / ACCESSWIRE / April 25, 2017 /The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Lion Biotechnologies, Inc. ("Lion Biotechnologies") (NASDAQ: LBIO) between November 14, 2013 and April 10, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to:http://www.zlk.com/pslra-sa/lion-biotechnologies-inc?wire=1or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) through its former CEO Manish Singh, Lion was engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting the Company to potential investors that purported to be independent from the company when, in truth, they were paid promotions; (2) Singh engaged a notorious stock promotion firm to pay writers to publish articles about Lion on investment websites, as well as to coordinate the distribution of articles to thousands of electronic mailboxes; (3) Singh actively participated in the promotional work for the Company and understood that the promotion firm was using writers who would not disclose that Lion was indirectly compensating them for their publications; and (4) consequently, defendants' public statements were materially false and misleading at all relevant times.

If you suffered a loss in Lion Biotechnologies you have until June 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Copyright © 2017 accesswire. All Rights Reserved., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
10:23p Levi & Korsinsky, LLP Notifies Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 - LBIO
10:23p WEINGARTEN REALTY INVESTORS /TX/ : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
10:23p LION BIOTECHNOLOGIES INC : Levi & Korsinsky, LLP Notifies Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 - LBIO
10:23p World Pranoprofen Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and Markets
10:22p Earnings, tax announcement hopes boost equities
10:22p C H ROBINSON WORLDWIDE : .H. Robinson beats Street 1Q foreasts
10:22p SHUTTERFLY : reports 1Q loss
10:22p LEGGETT & PLATT INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
10:22p CREE : reports 3Q loss
10:22p BOFI : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Latest news
Advertisement
Hot News 
11.09%LVMH's Arnault swoops to take full control of Christian Dior
19.56%European shares firm as earnings, M&A back in play
5.51%Earnings boost equities with U.S. tax announcement eyed
8.03%AHEAD OF THE TAPE : Caterpillar Rally Has Heavy Lift To Endure -- WSJ
-8.06%CARPETRIGHT : says market tougher, shares tumble
Most Read News
04/24 Ahead of NAFTA talks, U.S. sets 20 percent duties on Canadian softwood lumber
02:31p Earnings boost equities with U.S. tax announcement eyed
10:28a Germany opposes key EU car emission test reforms -document
01:29a TOSHIBA TO START TAKING BIDS IN JUNE FOR ITS SWISS UNIT LANDIS+GYR : Kyodo
02:35aDJLVMH : to Buy Christian Dior Couture for EUR6 Billion
Most recommended articles
04/21 TWENTY FIRST CENTURY FOX : Government extends period for regulators to report on Sky-Fox merger
04:18p AT&T : unexpectedly loses postpaid subscribers in first quarter
04:16pDJNEWS HIGHLIGHTS : Top Energy News of the Day
04:12pDJSL GREEN REALTY : Concern Over Manhattan's One Vanderbilt Project Grows
04:10p TSX posts two-month high as banks, lumber shares rally